Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001015820-25-000077
Filing Date
2025-12-22
Accepted
2025-12-19 18:51:08
Documents
4
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 6-K a12182025ssbb6-k.htm 6-K 18343
2 EX-99.1 exhibit991announcementssbb.htm EX-99.1 22763
3 image.jpg GRAPHIC 10502
4 qiagen_logo.jpg GRAPHIC 69764
  Complete submission text file 0001015820-25-000077.txt   152569
Mailing Address HULSTERWEG 82 PL VENLO NETHERLANDS Netherlands 5912 PL
Business Address HULSTERWEG 82 PL VENLO NETHERLANDS Netherlands 5912 PL 31-77-35566-00
QIAGEN N.V. (Filer) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38332 | Film No.: 251588907
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)